What’s one penny stock that has 100x potential
Yes 100x not 10x , don’t even bother giving 10x 20x 😒
Yes 100x not 10x , don’t even bother giving 10x 20x 😒
I genuinely think the market is severely underpricing the asymmetric upside in $SAFX relative to where the Sustainable Aviation Fuel industry is heading over the next decade.
This isn’t another generic “green energy” ticker with no addressable market. SAF is rapidly becoming a regulatory and operational necessity for global aviation.
The key point most people miss:
aviation is one of the hardest sectors to decarbonize.
Unlike passenger vehicles, there is currently no scalable battery-electric solution for long-haul commercial aviation. Hydrogen infrastructure is decades away from broad implementation. That leaves SAF as the only commercially deployable pathway capable of materially reducing lifecycle emissions using existing aircraft fleets and airport infrastructure.
That’s why airlines, governments, and energy players are aggressively moving toward SAF adoption.
The global SAF market is projected to compound massively before 2030 due to:
CORSIA emissions compliance requirements
EU ReFuelEU Aviation mandates
U.S. IRA tax incentives (45Z)
Net-zero commitments from major airlines
Corporate ESG pressure on aviation operators
Now compare that macro backdrop to SAFX’s valuation.
What stands out to me technically/fundamentally:
• SAFX is positioning itself as an integrated SAF production platform rather than just a development-stage story.
• The Reno/New Rise facility gives them actual production infrastructure exposure, which materially differentiates them from purely conceptual SAF companies.
• Expansion plans indicate management is targeting scalable production economics rather than remaining niche capacity.
• Their strategy around multiple SAF pathways (HEFA, biomass-to-liquid, potential eSAF exposure) is important because feedstock diversification is likely to become a major competitive advantage in this industry.
• Capital raises and financing activity suggest management is focused on accelerating production scaling while the regulatory tailwinds are strengthening.
People also underestimate how constrained SAF supply currently is.
Demand projections from airlines are exponentially outpacing global production capacity. That imbalance is exactly what could drive long-term pricing power for producers that successfully scale early.
Another major factor:
traditional refiners and energy infrastructure companies are increasingly entering the SAF ecosystem because they recognize aviation fuel decarbonization is likely inevitable. If SAFX can successfully execute and expand capacity, the company becomes strategically more valuable in an industry where future consolidation is highly possible.
Catalysts I’m watching closely:
Reno facility expansion milestones
Increased annualized SAF production guidance
Additional financing or strategic partnerships
Offtake agreements with airlines or fuel distributors
Regulatory acceleration around SAF blending mandates
Potential rerating if institutional money rotates back into clean-energy infrastructure plays
Broader recognition of SAF supply shortages versus projected demand curves
The market is pricing many small-cap SAF names like the sector itself may fail, while the underlying industry data increasingly suggests the opposite: SAF adoption is probably unavoidable for commercial aviation over the long term.
If SAFX executes operationally and survives the scaling phase, I think people will look back at these valuation levels very differently.
Not financial advice just sharing my thesis after researching the sector pretty heavily.
Transaction will add an advanced magnet rare earths asset in Greenland to complement Skaergaard and solidifies Greenland Mines' position in the global critical minerals race
Neo Performance Materials will become a strategic shareholder and secures offtake rights for up to 60% of future Sarfartoq production
TRANSACTION HIGHLIGHTS
Key Takeaways
The Deal in Plain English
Greenland Mines Ltd. (NASDAQ: GRML) just signed an agreement to take over the Sarfartoq rare earth project in southwest Greenland from Neo Performance Materials Inc. (TSX: NEO; OTCQX: NOPMF). The price tag is US$35 million — US$20 million in cash, and US$15 million in Greenland Mines stock. [1]
Here is what makes this stand out for retail investors:
$LIMN
Entry above: $.30 🎯 $.33/$.36 🛑 $.28
$NIVF
Entry above: $1.18 🎯 $1.30/$1.45 🛑 $1.10
$PCLA
Entry above: $1.80 🎯 $2.00/$2.20 🛑 $1.70
$RGTZ
Entry above: $9.20 🎯 $9.50/$10.00 🛑 $8.95
Note: These are trade ideas based on break-out levels, once they hit entry & start moving up, consider raising your stops to protect your profits and protect your downside according to your own trading plan :). MadMaverick personally trades these on either the 2 or 3 minute timeframes, waiting for a candle to close over the entry level.
Although we do extensive research for our watchlist, day trading, especially with low-float stocks, can be risky.
EDIT: Putting this here as it seems fairly bullish. @HelloBeautifulz just linked their Android dev page & Apple App store page. Looks like there's some big names who've contracted their system. Warner Bros, EA, Adobe included. https://play.google.com/store/apps/developer?id=CXApp&hl=en_US
https://apps.apple.com/us/developer/cxapp-us-inc/id692960350
Just full transparency, I used Claude to help me do a deep-dive into the stock after seeing it pop up on my feed. When I see something pop up I look for reasons not to buy but honestly the actual company seems to have real long-term potential, meaning it could be a relatively (strong emphasis on relatively) safe micro to buy and hold (at least right now as it's price is under $1 with cap at just $12m).
I think one of the key things keeping it down is the risk of dilution, which actually scales back exponentially if prices rise, deeper explanation in the analysis below. CXAI has this large open capital facility they can draw from in exchange for their stocks, they've done so in the past to raise cash for whatever their company has needed. Right now things are different than they expected (their stock price). The CFO's said that regaining compliance (getting the price above $1 before September) is a big goal of theirs that they believe they can achieve this organically. For that to happen they would have to stop further dilution for the foreseeable future, which is very possible with their current cash reserves.
I also went through SEC filings and I grilled their full situation. Sorry for so much content but each section was a bit I really critiqued alongside Claude to explore the ramifications.
For informational purposes only. Not financial advice. All investments carry risk of total loss. Consult a licensed financial advisor before making any investment decisions.
A Gartner-recognised, Google Cloud-featured, Fortune 500-serving enterprise AI software company with 83% gross margins is trading at a price where you buy the cash on the balance sheet at par value and get the entire business for free — with a simple doubling of the stock price requiring only the most basic minimum valuation that any software company should receive.
CXApp builds the AI operating layer for large enterprise workplaces. Its platform — used by Fortune 500 companies across technology, financial services, healthcare, and manufacturing — connects and automates the fragmented systems that manage how employees interact with their physical and digital work environment. Think desk booking, meeting room management, indoor navigation, visitor management, occupancy analytics, and corporate communications — unified into a single AI-native platform that autonomously orchestrates these workflows rather than simply responding to manual requests.
Its Zero-Touch Campus Deployment tool reduces what previously took weeks of manual configuration to minutes. Its One Map Experience provides real-time spatial intelligence across global campuses. These are genuine technical innovations that create high switching costs once deployed — enterprises don't remove a system embedded in their core workplace infrastructure without significant pain.
The company is headquartered in Palo Alto, has 35 employees, and serves customers across more than 100 countries. Over 70% of the team is engineering-focused. It went public in March 2023 via a SPAC merger.
CXApp's stock is not depressed because the business is failing. It is depressed because of a specific financing arrangement called the Avondale Capital pre-paid purchase facility.
Here is how it works. A company called Avondale Capital paid CXApp fixed dollar amounts upfront — primarily a $4 million tranche signed in March 2025 when the stock traded at $1.06 per share. In exchange, CXApp agreed to deliver shares to Avondale over time as repayment. The shares being delivered today are therefore largely repayment of cash received months ago — not fresh dilutive raises chosen at today's depressed prices.
The critical structural feature is that the number of shares delivered is variable — calculated at the prevailing market price at the time of delivery. This means the more the stock falls, the more shares must be delivered per dollar of pre-paid obligation. Between December 2025 and April 2026, approximately 29 million new shares were issued to Avondale at prices between $0.14 and $0.35, roughly doubling the share count from approximately 35-40 million to approximately 70 million. This flood of new supply has suppressed the stock price — which in turn requires even more shares per dollar delivered, creating a self-reinforcing downward pressure.
The remaining facility totals approximately $38.95 million — which sounds alarming. But here is the insight that makes this situation fundamentally different from typical dilution stories. Because the shares are delivered at prevailing market prices, the dilutive cost falls dramatically as the stock rises.
At $0.17 — drawing $1M costs approximately 6 million new shares. At $1.00 — that same $1M draw costs approximately 1 million shares. At $3.00 — approximately 350,000 shares. At $10.00 — approximately 100,000 shares.
The $38.95M facility implies 270 million potential new shares at today's price — catastrophic dilution. At $1.00 it implies only 46 million. At $3.00 just 15 million. The threat does not require repayment. It dissolves automatically as the stock price recovers.
This creates a self-reinforcing recovery dynamic. If Avondale draws slow or stop and the stock begins recovering toward $1.00, two things happen simultaneously — remaining delivery obligations become less dilutive, and the market's fear discount applied to the facility shrinks. Both effects accelerate the re-rating. The same recovery that generates investment returns simultaneously destroys the primary risk.
Gartner Magic Quadrant Visionary — April 2026
Gartner independently evaluated CXApp and named it a Visionary in the inaugural Gartner Magic Quadrant for Workplace Experience Applications. Gartner requires demonstrated customer deployments and verified market execution — this is not a paid recognition. It generates automatic inclusion in enterprise procurement shortlists globally, giving a 35-person company a sales channel it could never replicate through direct effort alone.
Google Cloud Featured Case Study — Google Cloud Next 2026
At one of the world's largest enterprise technology conferences, Google selected CXApp to showcase exemplary analytics architecture. Google's Director of Outbound Product Management personally endorsed the approach. This is independent third-party validation from one of the world's most credible technology organisations.
Cisco Spaces Preferred Partner
CXApp is designated as a preferred partner for Cisco Spaces — Cisco's enterprise workplace management platform. This gives CXApp a channel into Cisco's vast enterprise installed base without the cost of a dedicated sales force.
Fortune 500 Customers Renewing At 130% ARR Expansion
Three major Fortune 500 customers renewed with combined annual recurring revenue expansion above 130%. In enterprise software, customers expanding contracts at this rate are not making mistakes — they are paying more because the platform solves real problems more effectively than alternatives.
Three Competitive RFP Wins In Q1 2026
Three new multi-year enterprise agreements spanning 100+ countries, won through competitive evaluations against larger, better-funded vendors including Microsoft and ServiceNow. The consistent winning factor was AI-native architecture and agentic AI capabilities — precisely what enterprise procurement teams are now demanding as a condition of selection.
83% GAAP Gross Margins
Salesforce operates at approximately 74% gross margins. ServiceNow at approximately 78%. CXApp at 83% means exceptional unit economics — each new dollar of revenue flows overwhelmingly to the bottom line rather than being consumed by delivery costs.
The Market
The digital workplace market is estimated at $77 billion in 2026, projected to exceed $160 billion by 2030. The AI agent market alone is projected to exceed $100 billion by 2030. Enterprise demand has shifted from AI experimentation to production-scale deployment — with agentic AI capabilities increasingly becoming a condition of procurement. CXApp built for this paradigm before competitors began retrofitting for it.
Cash: $12.3M confirmed The Form 10-Q filed with the SEC on May 13, 2026 confirms cash and cash equivalents of exactly $12,342,000 as of March 31, 2026. At a current market cap of approximately $12 million, the enterprise value of the operating business is effectively zero. The market is pricing the business itself as worthless — the Avondale discount creates this distortion.
Operating burn: decelerating Q1 2026 operating cash use was $2.21 million — substantially improved from the $13.47 million annual loss in 2025. Cash actually increased quarter-on-quarter from $11.1M to $12.3M. At current burn rates, the existing cash provides approximately 5-6 quarters of runway without any further Avondale draws.
Revenue quality: exceptional 98% of revenue is recurring subscription revenue. $2M in deferred revenue represents contracted future income already recognised regardless of new sales. Q1 2026 bookings of $1.4M exceeded recognised revenue of $0.95M — a lead indicator that Q2 revenue is accelerating as the three new enterprise wins begin converting.
CEO Khurram Sheikh — Stanford-trained engineer with 12 issued US patents. Career spanning mobile networks, IoT, and enterprise software. Founded KINS Technology Group specifically to bring CXApp public — a genuine technology vision backed by operational credibility with the Fortune 500 CTOs who are CXAI's buyers.
Board Member Di-Ann Eisnor — Co-founded Waze, acquired by Google for over $1 billion. Direct experience scaling a platform business combining spatial intelligence, real-time data, and network effects — precisely CXApp's domain.
CFO Joy Mbanugo — 22 years of financial leadership spanning Ernst & Young, BlackRock, Google Cloud, and SaaS CFO roles. At Google she managed cash systems processing over $100 billion and contributed to one of the company's largest financial transformations. At ServiceRocket she optimised EBITDA while driving growth in a directly comparable B2B SaaS business. She holds both accounting and law qualifications — rare and valuable for a company navigating simultaneous SEC compliance, Nasdaq requirements, and complex financing arrangements. Her personal motivation to establish an exceptional public company CFO track record in this first listed company role gives her incentives that are directly aligned with shareholders.
At $0.34 per share — double from today — the market cap would be approximately $24 million. Subtract $12.3 million in cash, and the enterprise value assigned to the operating business would be approximately $11.7 million. On a $4-6 million forward revenue run rate, that's a price-to-sales ratio of 2-3x.
Enterprise software companies with 80%+ gross margins virtually never trade below 3x price-to-sales outside of acute distress. Salesforce has never traded below 5x in its public company history. ServiceNow never below 7x. A double simply moves CXAI from an irrational extreme to the absolute minimum floor of what any functioning enterprise software business should command.
This is not a dramatic re-rating thesis. It is the removal of an irrational discount.
These catalysts are connected — Avondale draws slowing causes the stock to rise, which makes Nasdaq compliance easier to achieve organically, which unlocks institutional buyers, which pushes the stock higher still, which further reduces the Avondale dilution overhang. The first domino falling makes every subsequent one more probable.
Near-term — The Easy Double Avondale draws slow, Q2 revenue inflects, Nasdaq compliance resolved. Stock moves to $0.34-$0.50, representing 2-3x from today on minimum SaaS valuation alone.
2026 — The Inflection Year Revenue reaches $5-6M as enterprise wins convert. Market cap: $15-48M. Return: 1.3-4x.
2027 — The Scaling Year Revenue scales to $12-18M as Gartner pipeline converts and existing customers expand. Company approaches EBITDA breakeven — the single most transformative event for institutional re-entry. Market cap: $60-180M. Return: 5-15x.
2028 — The Compounding Year Revenue reaches $22-30M. Operating profitability. Market cap: $130-360M. Return: 11-30x.
Acquisition scenario At 5-8x forward revenue on a $15M run rate — a $75-150M offer represents a 6-12x return. Tuck-in acquisitions in enterprise SaaS at this quality profile are common and typically arrive without warning.
Probability-weighted expected value over three years
Worst case — Avondale continues, revenue flat, near-total loss: 30-35% probability
Base case — Avondale resolves, revenue grows to $15-20M, 8-15x return: 40-45% probability
Best case — Avondale stops, revenue accelerates, acquisition or re-rating, 15-30x return: 20-25% probability Probability-weighted expected value: approximately 8-10x.
The one number to watch Check SEC EDGAR for CXApp 8-K filings weekly. The day Avondale issuance disclosures stop is the day the return clock starts.
Avondale facility ($38.95M remaining) — The dominant risk. At $0.17, continued draws at the January-April 2026 pace could triple the share count. Severity is directly linked to the stock price and diminishes exponentially above $1.00 — but if draws continue at pace the investment thesis is severely challenged.
Nasdaq compliance deadline (September 2026) — May require a reverse split which would initially suppress the price before any recovery. First-time reverse split on a genuinely quality business is less destructive than serial splits on shells, but the initial reaction is typically negative.
Revenue must visibly recover — The 36% revenue decline in 2025 must be demonstrated as reversed in Q2 and Q3 data. Bookings signals are encouraging but not yet confirmed in recognised revenue.
Competitive pressure — Microsoft Viva, ServiceNow, and Zoom are all building workplace AI capabilities with vastly greater resources. CXApp's architectural depth and Gartner recognition provide a moat, but not an impenetrable one.
Execution risk — 35 people simultaneously delivering multi-country enterprise deployments is operationally stretched. A service quality failure at a key customer could trigger churn that undermines the recovery thesis.
These risks are known, specific, and measurable — which is genuinely preferable to hidden risks. Each has a specific counterweight in the business quality, cash position, and self-reinforcing recovery mechanics.
CXApp is an enterprise AI software company — think AI-powered workplace management for Fortune 500 companies — that is trading at essentially zero enterprise value because of a specific financing arrangement called the Avondale Capital facility. Under this arrangement, a financial company called Avondale paid CXApp cash upfront in 2025 and is receiving shares as repayment. Because the shares are delivered at prevailing market prices, this flooded the market with new supply and suppressed the stock — but the dilutive threat dissolves automatically as the stock recovers, since each dollar of remaining obligation requires fewer shares at higher prices.
The business underneath this temporary distortion is genuinely exceptional. Gartner independently validated it. Google Cloud featured it. Fortune 500 customers are renewing contracts at 130% expansion rates. Three new enterprise wins covering 100+ countries were secured in Q1 2026. The gross margins of 83% exceed Salesforce and ServiceNow. The CEO is a Stanford engineer with 12 patents. Waze's co-founder sits on the board. The company has $12.3M in verified cash — roughly equal to the entire market cap — meaning you are buying the cash at par and receiving the business for free.
A simple doubling of the stock price requires only the most basic minimum valuation any enterprise software company should receive — 2-3x price-to-sales on the operating business. Seven specific, connected catalysts are already in motion that could trigger this without extraordinary events. And the long-term upside — 5-30x as the business scales toward profitability or attracts acquisition interest — is the mathematical consequence of a quality business beginning to trade at the multiples it deserves.
The timeline is measured in months, not years.
Not financial advice. Based on publicly available information as of May 2026. All investments carry risk including total loss of capital. Conduct your own due diligence and consult a licensed financial advisor before making any investment decisions.
Hey guys, if you missed it, CytoDyn just settled $500K with investors over claims it misled the market about its drug leronlimab some time ago. And they have already sent the agreement to the court for final approval.
In a nutshell, in 2021, CytoDyn was accused of overstating the effectiveness and regulatory progress of leronlimab. In short, the FDA later said the company’s claims were not supported by data, revealing no clear benefit.
After this news came out, the stock dropped 25%, and investors filed a lawsuit for their losses.
The good news is that the company recently agreed to settle $500K with them, and already sent this agreement to the court for final approval. So, if you invested in $CYDY when all of this happened, you can check the details and file your claim here.
Anyway, has anyone here invested in $CYDY at that time? How much were your losses, if so?
Most people who followed $CYDY remember March 30, 2021. The FDA publicly stated that CytoDyn's claims about leronlimab were "misleading and not supported by the data", no benefit was shown in COVID-19 treatment trials. The stock dropped 25%+ that day.
What happened afterward was a class action lawsuit covering investors who held $CYDY between March 27, 2020 and March 30, 2022.
A $500,000 settlement has been reached and terms are now submitted to the court for approval.
Who qualifies?
Anyone who held $CYDY during the class period and suffered losses from the alleged misrepresentations about leronlimab's effectiveness for HIV and COVID-19.
Can I still apply?
Yes, you can submit your application now and it will be processed once claims filing officially opens after court approval.
If you were damaged by this don't forget to check your eligibility. GL!
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.1318. The range of purchase prices on the transaction date was $0.1309 to $0.1369 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
OK let's settle this debate once and for all. people are genuinely having a tug of on where price will go. I think we're guaranteed to atleast make .50 cents and the problem is, some people think it'll only peak their, some people think it can't go higher than $1-$2, a select few thinks 10 dollars is the price point. We have to take a few things into consideration before speculating where price can go.
Why i think $0.50 is just the Warm up
the people saying this tops out at $0.50 completely misunderstand Eric Jackson's personal incentives. He isn't putting his institutional reputation on the line to run a 50-cent penny stock.
According to the SEC filings, Eric Jackson’s massive performance stock options only unlock when the combined company hits two massive valuation targets:
Milestone 1: Hitting a $1 Billion Market Capitalization (Unlocks a 12% stake).
Milestone 2: Hitting a $2 Billion Market Capitalization (Unlocks a 20% stake).
Right now, SRXH has a micro-cap valuation sitting at roughly $45M to $80M. If the post-merger share pool lands around 500 million shares, the math dictates the stock price milestones:
To hit the $1 Billion milestone, the stock must reach ~$2.00.
To hit the $2 Billion milestone, the stock must reach ~$4.00.
Ej's entire payday is legally tethered to driving the stock into the $2.00 to $4.00 range. a $0.50 peak would mean he fails to capture his primary incentives.
When a stock moves 10% to 20% in a couple of days, it hits the radar of Stock Screeners across Wall Street. Thousands of day traders wake up, open their software, and scan for "Top Percentage Gainers" and "Highest Relative Volume."
Suddenly, $EMJX is one of the popular stocks flashing on every scanner in the country due to the volatility.
Late traders, FOMO (Fear of Missing Out) buyers, and "dumb money" don't care about the S-4 filing. They just see a green vertical line on a chart.
They flood the market with market buy orders. Because the 418 million insider shares are legally locked up and cannot be sold, there is no supply to meet this massive wave of demand. The sheer velocity of millions of retail dollars chasing a tiny, locked float is what violently forces the price past $1.00, through $2.00, and up toward those multi-billion dollar milestone targets.
alr now for you $5 to $10 activists
you understand that once the social media FOMO machine merges with a locked institutional float, the stock will heavily overshoot its actual value due to pure mechanical momentum (just like Carvana did).
so plan your exits around this information all based on history and the SEC filings. I myself aint selling till this stock atleast reaches $2 minimum, and im not holding past 5 dollars most likely, anything else I agree would probably be long term but again it could genuinely shoot up to $10 per share.
What happened to all the hype around this tanker stock? I am down 40%. Hold on or take the loss?
That’s the headline of this article at Yahoo finance.
https://finance.yahoo.com/sectors/healthcare/articles/forget-242-biotech-meme-brain-153927239.html
PSTV- I bought into this stock after it was mentioned in this group (always do your own research) and I’m starting to see real gains. And it just started spiking even more. Thanks whoever you are!
EDIT: @HelloBeautifulz just linked me their Android dev page & Apple App store page. Looks like there's some big names who've contracted their system. Warner Bros, EA, Adobe included. https://play.google.com/store/apps/developer?id=CXApp&hl=en_US
https://apps.apple.com/us/developer/cxapp-us-inc/id692960350
Hi everyone, this is further research I've done and acts as a follow on to my post yesterday about CXAI. Feeling pretty great about what I've uncovered but please do your own research. Again, I used Claude to help collate everything.
For informational purposes only. Not financial advice. All investments carry risk of total loss. Consult a licensed financial advisor before making any investment decisions.
1. CEO's Interests Are Identical To Every Ordinary Shareholder CEO Khurram Sheikh holds 6.65 million ordinary shares with zero anti-dilution protection. Every Avondale delivery has already cost him proportionally. His personal wealth at $10 per share would be $66.5 million — achievable only through the same outcome every shareholder needs.
2. The Dilution Was Prior Contractual Obligation, Not An Active Choice Three pre-paid purchase agreements signed in 2025 at stock prices between $0.40 and $1.06 obligated CXApp to deliver shares as repayment of upfront cash already received. The January through April deliveries were honouring those prior commitments — not decisions made at $0.17 to sell equity cheaply.
3. The Dilution Appears To Have Already Stopped — 34 Days And Counting The last Avondale share delivery was filed April 17, 2026. As of May 21 — 34 consecutive days — no new SEC filing has appeared. Prior deliveries occurred at least every two weeks without exception. The five-week silence is consistent with prior contractual obligations having been fulfilled.
4. The Remaining Dilution Threat CXAI still have access to but no obligation to use an arranged capital facility with Avondale, this is different to their pre-paid agreement which they paid out in shares from January to April. Given the other signals, it's seems very unlikely they would use this facility any time soon as it would impact not just their goal of compliance but also the owner's shares significantly.
5. 41 Institutional Investors Including Vanguard And Renaissance Technologies Hold Positions Some of the world's most sophisticated investment organisations have evaluated and invested in CXAI. Vanguard Personalized Indexing Management holds 25,796 shares and increased its position by 93.4% in the most recent quarter. It's not a lot of shares for them, but the fact that they would increase the amount they hold in the recent quarter means they see value here.
Many more institutional funds cannot currently hold the stock due to Nasdaq compliance mandates — resolution unlocks them simultaneously.
6. The Company Is Net Cash Positive With Conventional Debt $12.3M in SEC-verified cash against $9.4M in conventional long-term debt leaves the company net cash positive. At a $12M market cap, the operating business is valued at zero — the entire share price is backed by cash alone.
7. Gross Margins Of 87% Exceed Salesforce And ServiceNow 87% GAAP gross margins mean each new revenue dollar generates 87 cents of gross profit. As revenue scales toward $11-18M over two to three years, the operating leverage is powerful and EBITDA breakeven is achievable at modest revenue levels.
8. Revenue Declined For Quality Reasons — Leading Indicators Point To Recovery The prior revenue decline was deliberate — shedding low-margin professional services to build a pure subscription model. Gross margins expanded 5 points as a direct result. Q1 2026 bookings exceeded recognised revenue, three enterprise wins worth $5M total contract value are converting, and CXAI 2.0 launches June 2026. Q2 results in August are the first objective proof point.
Kins Capital LLC — CEO Khurram Sheikh's personal vehicle — holds 6,650,000 ordinary shares, approximately 11.65% of the company. These carry no anti-dilution protections, no preferred conversion rights, and no special exit mechanisms.
His only path to wealth creation is the same path every other ordinary shareholder needs — the stock price rising and sustaining.
How Dilution Has Already Cost Him
Before Avondale deliveries began his stake represented approximately 17-19% of the company. As the share count doubled to approximately 70 million shares through deliveries, it has fallen to approximately 9.5%. His proportional ownership has nearly halved through the same dilution that affected every ordinary shareholder.
The Personal Wealth Mathematics
At $0.17 (current) — approximately $1.13 million. At $0.34 (double) — approximately $2.26 million. At $1.00 (Nasdaq compliance) — approximately $6.65 million. At $3.00 — approximately $19.95 million. At $5.00 — approximately $33.25 million. At $10.00 — approximately $66.5 million.
Every dollar the stock rises benefits Sheikh and every ordinary shareholder in identical proportion. His incentive to stop dilution and drive recovery is directly quantified — not theoretical.
How The Facility Works
Avondale Capital paid CXApp fixed dollar amounts upfront. CXApp delivered shares over subsequent months as contractual repayment — calculated at the prevailing market price at each delivery date. The deliveries of January through April 2026 repaid cash received months earlier when the stock was significantly higher.
The Four Agreements — All Signed At Higher Prices
Pre-Paid Purchase #1 — March 26, 2025. Stock price approximately $1.06. Pre-Paid Purchase #2 — August 7, 2025. Stock price approximately $0.60. Pre-Paid Purchase #3 — October 17, 2025. Stock price approximately $0.40. New $40M Ongoing Optional Draw Facility — March 27, 2026. Stock price $0.17. Initial $990K drawn. $38.95M undrawn.
The majority of stock deliveries in January through April were honoring obligations signed 4-12 months earlier at significantly higher prices — a fundamentally different management quality signal than executives actively choosing to dilute at distressed prices.
Complete SEC 8-K Delivery Record
January 26-28, 2026: 4,616,481 shares — Pre-Paid Purchase #1. Price: $0.24024 per share. Proceeds: approximately $1.11M.
February 17 — March 23, 2026: 10,028,891 shares — Pre-Paid Purchases #1 and #2, six dates. Prices: $0.156793 to $0.199381 per share. Proceeds: approximately $1.75M.
March 30 — April 10, 2026: 4,116,659 shares — Pre-Paid Purchases #1 and #2, four dates. Prices: $0.154427 to $0.180453 per share. Proceeds: approximately $740K.
April 13-17, 2026: 7,304,178 shares — Pre-Paid Purchases #2 and #3, three dates. Prices: $0.144872 to $0.154427 per share. Proceeds: approximately $1.07M.
Total delivered January through April 17: approximately 26,066,209 shares. Total gross proceeds: approximately $4.67 million.
The 34-Day Gap
Last Avondale 8-K: shares issued April 13-17, 2026. Today: May 21, 2026 — 34 consecutive days without a new filing.
Prior pattern: deliveries on at least fifteen separate dates across four months — never more than two weeks between filings. A five-week break is entirely inconsistent with that pattern and consistent with prior contractual obligations having been substantially or fully fulfilled.
Every additional week without a new filing strengthens this conclusion.
Because shares are delivered at prevailing market prices, the dilutive cost of any future Avondale draw is not fixed — it falls exponentially as the stock recovers.
Drawing $1M at $0.17 — approximately 6 million new shares. Drawing $1M at $1.00 — approximately 1 million shares. 83% less dilutive. Drawing $1M at $3.00 — approximately 350,000 shares. 94% less dilutive. Drawing $1M at $10.00 — approximately 100,000 shares. 98% less dilutive.
The full $38.95M remaining facility implies 270 million potential new shares at $0.17. At $1.00 it implies only 46 million. At $3.00 just 15 million.
This creates a self-reinforcing dynamic. If the 34-day gap confirms prior obligations are fulfilled and the stock begins recovering, two things happen simultaneously — remaining delivery obligations become less dilutive and the market's fear discount applied to the facility shrinks. Both effects accelerate the re-rating. The same recovery that generates returns simultaneously destroys the primary risk.
The Institutions
41 institutional owners have filed 13D/G or 13F forms with the SEC. Named holders include Vanguard Group, Renaissance Technologies, UBS Group AG, Geode Capital Management, Susquehanna International Group, Northern Trust, Bank of Montreal, HRT Financial, Virtu Financial, and DRW Securities.
Their presence confirms that systematic investment processes — involving analysts, risk managers, and investment committees — evaluated CXApp and determined it warranted a position. Renaissance Technologies in particular is known for identifying statistical mispricings through sophisticated quantitative analysis.
Vanguard's Specific Position
Vanguard Personalized Indexing Management LLC holds 25,796 shares of CXApp, valued at approximately $28,000 at the last reporting date. In the most recent quarter it purchased an additional 12,459 shares — increasing its position by 93.4%. A deliberate institutional decision to nearly double exposure in a $12M market cap company goes through significant internal review and represents genuine conviction.
The Locked-Out Buyer Wave
Many institutional funds operate under mandates prohibiting ownership of Nasdaq non-compliant stocks. These funds cannot hold CXAI today regardless of investment conviction. Nasdaq compliance resolution unlocks this entire category simultaneously — potential new demand with no corresponding increase in selling pressure.
Cash confirmed in SEC 10-Q May 13, 2026: $12,342,000. Long-term debt: approximately $9.4 million — conventional technology financing, no predatory rates. Net cash: approximately $2.9 million positive. Debt-to-equity: 0.97x. Net debt to EBITDA: negative 0.14x.
At a $12M market cap against $12.3M cash, the market is pricing the entire operating business — Gartner recognition, Fortune 500 customers, 87% gross margins, Google Cloud partnership, Cisco Spaces preferred partner status — at zero. The balance sheet is structurally sound with no toxic instruments.
GAAP gross margins of 87% in FY2025 expanded 5 points year-over-year through cloud-spend optimisation and transition to a single code base.
For comparison — Salesforce operates at approximately 74% gross margins. ServiceNow at approximately 78%. CXApp at 87% means each incremental revenue dollar is more profitable than at either of the world's leading enterprise software companies.
As revenue scales from the current $4.6M base toward $11-18M over two to three years, operating leverage is significant. Revenue doubling does not require anything near doubling of costs. EBITDA breakeven becomes achievable at relatively modest revenue scale, and profitability thereafter compounds rapidly.
The Full Revenue History
2024: $7.14M. 2025: $4.58M — down 36%. Q1 2026: $0.95M — approximately $3.8M annualised run rate.
The trend is declining. This must be stated honestly.
Why The Decline Was Deliberate And Quality-Improving
The 36% revenue decline was explicitly attributed to three factors: deliberate exit of non-core contracts and professional services, customer churn during a platform transition, and reduced bookings during the transition period.
The critical proof that this was a deliberate quality trade-off rather than a market failure: gross margins expanded from 82% to 87% simultaneously. It is impossible to shed revenue and improve gross margins unless the revenue you shed was lower-margin than what remained.
Think of it like a restaurant removing cheap takeaway from its menu to focus on premium dining. Revenue falls in the short term. Margin per customer rises. The long-term business quality improves.
Subscription revenue rose from 87% to 98% of total revenue as a direct result — completing the transition to a pure SaaS model. What remains is almost entirely recurring, contractually committed, high-margin revenue. The quality of the $4.58M revenue base today is genuinely superior to the $7.14M peak — even though the quantity is lower.
The Leading Indicators Of Recovery
Q1 2026 bookings of $1.4M exceeded recognised revenue of $0.95M. In enterprise SaaS, bookings lead recognised revenue by one to three quarters. Sustained bookings above recognised revenue means future revenue is already being built.
Three new enterprise wins with $5M total contract value are beginning to convert to recognised revenue in Q2 and Q3 2026.
A pipeline of 20+ enterprise opportunities is in active evaluation — many generated by the April 2026 Gartner Magic Quadrant Visionary placement which automatically puts CXApp on enterprise procurement shortlists globally.
CXAI 2.0 launches June 2026 — a significant platform release that typically accelerates new customer conversion and expansion upsell within the existing base.
Analyst consensus forecasts 57% annual revenue growth over two years — versus 16% for the broader US software industry: 2026: approximately $7.2M — recovering to 2024 levels. 2027: approximately $11.3M. 2028: approximately $17.7M.
Does The Revenue Support A Realistic Valuation?
At today's $3.8M annualised run rate — not yet. An $70M market cap implying $1.00 per share against $3.8M revenue is approximately 18x price-to-sales. That is high for a business still showing revenue decline.
At 2027 projected revenue of $11M — yes, and conservatively. Enterprise SaaS companies with comparable profiles — 80%+ gross margins, Gartner recognition, Fortune 500 customers, growing ARR — typically trade at 6-12x forward revenue.
Realistic Valuation Scenarios At 2027 Revenue
At $11M revenue — conservative 6x multiple: $66M market cap = $0.94 per share. At $11M revenue — base case 8x multiple: $88M market cap = $1.26 per share. At $15M revenue — base case 8x multiple: $120M market cap = $1.71 per share. At $11M revenue — growth premium 10x multiple: $110M market cap = $1.57 per share.
Realistic Acquisition Valuation Scenarios
Enterprise SaaS acquisitions at this quality profile — Gartner-validated, 87% gross margins, Fortune 500 customers — typically price at 4-6x forward revenue. At $11M 2027 revenue:
Conservative trade sale at 4x: $44M = $0.63 per share. Mid-range trade sale at 5x: $55M = $0.79 per share. Full premium trade sale at 6x: $66M = $0.94 per share.
Even the most conservative acquisition scenario implies approximately 4x from today's $0.17. Public market re-ratings at normal enterprise SaaS multiples imply 7-9x. These are not heroic assumptions — they are what comparable businesses actually trade at.
The investment thesis depends on the revenue inflection being real and the leading indicators converting to reported results. Q2 earnings in August 2026 are the first objective confirmation. Until then, the thesis is supported by strong signals but unproven in reported numbers.
The CEO's personal wealth is directly and quantifiably tied to the same outcome every ordinary shareholder needs — with zero protective structure.
The dilution was contractually obligated under agreements signed at higher prices and appears to have already stopped based on 34 consecutive days of SEC filing silence.
The remaining dilution threat in the $38.95M undrawn facility dissolves automatically and exponentially as the stock recovers — making recovery self-reinforcing.
41 institutional holders including Vanguard and Renaissance Technologies have already validated the investment case, with an entire wave of compliance-restricted institutional buyers ready to enter upon Nasdaq resolution.
The balance sheet is net cash positive with conventional debt. The market is pricing the operating business at zero.
Gross margins of 87% are exceptional and create powerful operating leverage as revenue scales.
The revenue decline was a deliberate quality trade-off — shedding low-margin services to build a pure subscription base. The proof is simultaneous gross margin expansion. Leading indicators including bookings, enterprise wins, analyst consensus of 57% growth, and the June 2026 CXAI 2.0 launch all point toward recovery.
The $70M market cap required for $1.00 per share is justified by conservative 6-8x multiples on 2027 projected revenue — the minimum any Gartner-validated, 87% gross margin, Fortune 500-serving enterprise SaaS company should command. Even the most conservative acquisition scenario implies 4x from today's prices.
Not financial advice. Based on publicly available information as of May 21, 2026. All investments carry risk including total loss of capital. Consult a licensed financial advisor before any investment decisions.
At today’s beaten-down valuation, Rekor Systems screens like one of those rare micro-cap dislocations where the market has basically priced in near-permanent impairment… rather than a messy but fixable capital structure problem and a classic sentiment wipeout.
Strip the noise away and the setup is actually pretty simple: this is an AI infrastructure + ALPR + public safety data business sitting right in the middle of the global shift toward automated enforcement, real-time surveillance intelligence, and data-led policing. Whether people like that trend or not, it’s happening — and it’s not slowing down.
The bear case is basically: cash burn, dilution, compliance risk, end of story.
But the bull case is far more boring — and that’s exactly why it’s interesting:
Rekor doesn’t need a miracle product. It needs:
capital breathing room
no forced dilution spiral
continued execution on existing contracts
That’s it.
And the reality is the business is already doing tens of millions in annual revenue, with a solid pipeline and backlog of government and municipal work. In this part of the market, that alone can be enough for a violent re-rate once the “going concern / survival” narrative clears.
Right now the entire valuation is basically one thing: trust in survival. Not growth.
Most people still look at ALPR like it’s just cameras on poles.
That’s outdated thinking.
The real asset is:
the data network
the recognition + inference pipeline
the integration layer into enforcement systems
Once ALPR is embedded into city infrastructure, it becomes sticky in a way investors consistently underestimate:
multi-year municipal contracts
brutal switching costs
dataset compounding (models improve with scale)
deep integration into policing, tolling, traffic enforcement
This isn’t hardware. It’s infrastructure-level AI surveillance plumbing.
And infrastructure doesn’t churn easily once it’s in.
Here’s the twist most retail misses.
Yes, privacy regulation is a headwind. But it also forces consolidation.
If legislation trends toward:
audited data usage
certified vendors only
secure and accountable infrastructure requirements
Then the fragmented “random vendor” ecosystem gets squeezed out.
That tends to benefit exactly the kind of player Rekor is trying to be: already integrated, already working with government, already operating under procurement frameworks.
In other words: regulation doesn’t kill the category — it just decides who gets to play.
This is where it starts to get interesting.
The upcoming deepfake-focused Q3 GoSecure product launch (AI-driven media verification / fraud detection / identity trust layer) is not just a side feature — it potentially expands Rekor’s addressable market beyond ALPR into:
identity verification ecosystems
digital evidence validation
fraud prevention / synthetic media detection
broader “trust layer” infrastructure for public safety AI
In a world where deepfakes are rapidly eroding confidence in visual data, anything tied to verification, authenticity, and evidentiary integrity becomes strategically valuable.
And crucially, Rekor already has:
existing government relationships
procurement access
governance frameworks in place
So instead of starting from zero in a new market, they’re essentially bolting a new AI vertical onto an already embedded public-sector footprint.
That’s a rerating catalyst the market is not pricing in at all yet.
In a world moving toward AI-driven surveillance, smart cities, and real-time risk modelling, it’s not crazy to think larger ecosystems eventually consolidate around a few data ingestion and analytics layers.
Names like Palantir Technologies naturally get mentioned in this context, as do infrastructure/security players like Motorola-style ecosystems.
Not because acquisition is imminent — but because the direction of travel is obvious:
governments want integrated stacks
fragmented tools get consolidated
data fusion becomes more valuable than point solutions
Rekor sits closer to the data ingestion + real-world signal layer than most investors appreciate.
That’s the unsexy part… but often the most defensible.
Private players like Flock Safety are valued in the multi-billion range (aprox 7.5 Billion), and that comparison alone creates a weird asymmetry.
Because it forces a question:
If private markets are valuing similar infrastructure AI exposure at premium multiples… why is the public comp trading like a distressed optionality stub?
The answer right now is simple: balance sheet fear overrides everything.
But if that fear fades, even partially, the catch-up potential is significant.
This isn’t a “one headline” re-rating story. It’s a stack:
refinancing / liquidity stabilisation / forecasted EBITA positive end of 2026
removal of dilution overhang
improving visibility on contracts & margins
continued government wins
AI narrative expansion (deepfake + trust layer angle)
gradual removal of “going concern” stigma
Once financing risk is off the table, multiple compression does the rest. Fast.
That’s how these things move — violently, not gradually.
Conclusion
Rekor today looks less like a broken business and more like a capital-constrained infrastructure AI platform trading under liquidation gap psychology.
If management stabilises funding and avoids a dilution spiral, the upside isn’t about reinventing the company — it’s about the market snapping back from distress pricing to something closer to reality.
And in that shift, you don’t need perfection.
You just need survival, sentiment rotation, and a sector that suddenly remembers it still believes in AI infrastructure again.
GPUS partner tier with AGIBOT PTE. LTD. ("AGIBOT"), a developer of intelligent robotics technology, and we are the first American company to reach it.
I know mega-cap AI has carried the market, but small caps are where the ridiculous moves can happen when risk appetite comes back.
Yesterday’s microcap action reminded me how fast these things can move when volume shows up. Names like INM, AMST, CNEY, NXXT, WNW and GIPR were exactly the kind of “blink and it’s already up 80%” movers that make people start scanning again.
I’m trying to separate garbage momentum from actual multi-year setups.
My watchlist right now:
NXXT - energy / mobile fueling / momentum
AMST - AI education angle
INM - biotech speculation
SOUN - AI voice, bigger than penny but still volatile
LUNR - space infrastructure
NRED - tiny copper exploration exposure
The hard part is sizing. These are not “put your retirement in it” names. But a small basket of asymmetric names can be interesting if one or two actually work.
What small cap do you think has real business upside, not just chart hype?
$HCWB was laid out live in the server from the $1.53 entry with levels, trims, stop updates, and runner targets all posted in real time.
The call channel is currently OPEN FOR FREE members to view for a short time only.
First trims were called around the $1.76-$1.83 area, then runners were held for the bigger move with $3+ mentioned as the stretch target.
It ended up hitting $3.80 for a new high of day and a 148% play.
A lot of people only post the final result after the move is over, but everything in our channel is laid out as it happens so members can actually follow the process and risk management behind the trade.
Share buyback at .21 current price .14
earnings call after hours today, partnership with robots, treasury plans, over 800btc/94m cash and holdings
sitting around 52w lows
nfa. do your own dd